| Product Code: ETC6015129 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Pharmacogenetic Testing Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Afghanistan Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Afghanistan Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Afghanistan Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of personalized medicine in Afghanistan |
4.2.2 Rising prevalence of chronic diseases requiring personalized treatment |
4.2.3 Growing investments in healthcare infrastructure and technology in the country |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals for interpreting pharmacogenetic test results |
4.3.2 Lack of standardized regulations and guidelines for pharmacogenetic testing in Afghanistan |
4.3.3 Affordability issues for patients in accessing pharmacogenetic testing services |
5 Afghanistan Pharmacogenetic Testing Market Trends |
6 Afghanistan Pharmacogenetic Testing Market, By Types |
6.1 Afghanistan Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Afghanistan Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Afghanistan Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Afghanistan Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Afghanistan Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Afghanistan Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Afghanistan Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Afghanistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Afghanistan Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Afghanistan Pharmacogenetic Testing Market Export to Major Countries |
7.2 Afghanistan Pharmacogenetic Testing Market Imports from Major Countries |
8 Afghanistan Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of accredited laboratories offering pharmacogenetic testing services in Afghanistan |
8.2 Percentage of healthcare providers trained in pharmacogenetics |
8.3 Adoption rate of pharmacogenetic testing by healthcare facilities in the country |
9 Afghanistan Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Afghanistan Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Afghanistan Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Afghanistan Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here